Viking Global Opportunities Parent GP LLC's Net Worth

$1.48 Billion

Estimate Recalculated Mar 1, 2024 09:02PM EST

Who is Viking Global Opportunities Parent GP LLC?

Viking Global Opportunities Parent GP LLC has an estimated net worth of $1.48 Billion. This is based on reported shares across multiple companies, which include Amylyx Pharmaceuticals, Inc., RayzeBio, Inc., 4D Molecular Therapeutics, Inc., Roivant Sciences Ltd., BridgeBio Pharma, Inc., Ginkgo Bioworks Holdings, Inc., Rallybio Corp, Frazier Lifesciences Acquisition Corp, Inhibrx, Inc., and PROCEPT BioRobotics Corp.

SEC CIK

Viking Global Opportunities Parent GP LLC's CIK is 0001886738

Past Insider Trading and Trends

2023 was Viking Global Opportunities Parent GP LLC's most active year for acquiring shares with 15 total transactions. Viking Global Opportunities Parent GP LLC's most active month to acquire stocks was the month of August. 2022 was Viking Global Opportunities Parent GP LLC's most active year for disposing of shares, totalling 22 transactions. Viking Global Opportunities Parent GP LLC's most active month to dispose stocks was the month of August. 2022 saw Viking Global Opportunities Parent GP LLC paying a total of $72,238,379.62 for 299,350,986 shares, this is the most they've acquired in one year. In 2023 Viking Global Opportunities Parent GP LLC cashed out on 24,882,756 shares for a total of $181,200,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Amylyx Pharmaceuticals, Inc. (AMLX) Snapshot price: $15.275

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-10.26%
-1.40M
$29.80
-$41,719,639.31
12.24M
Sep 8 - Sep 9
Form 4
7.17M
$19.00
$43,700,000.00
7.17M
Jan 11 - Nov 11
Form 3
0
0
No matching records found

RayzeBio, Inc. (RYZB) Snapshot price: $62.13

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-6.64M
0
Feb 26
Form 4
-100.00%
-6.64M
0
Feb 26
Form 4
6.64M
$18.00
6.64M
Sep 19
Form 4
6.64M
$18.00
6.64M
Sep 19
Form 3
0
0
Form 3
0
0
No matching records found

4D Molecular Therapeutics, Inc. (FDMT) Snapshot price: $28.4887

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-11.28%
-540.00K
$19.53
-$10,546,200.00
4.25M
Jan 4
Form 4
+21.59%
850K
$16.00
$13,600,000.00
4.79M
May 9
No matching records found

Roivant Sciences Ltd. (ROIV) Snapshot price: $10.395

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-14.73%
-13.00M
$9.90
-$128,700,000.00
75.24M
Jun 22
No matching records found

BridgeBio Pharma, Inc. (BBIO) Snapshot price: $33.62

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-5.63%
-1.50M
$35.00
-$52,500,000.00
25.12M
Jul 18
No matching records found